Advanced BioScience Laboratories, Inc.
ALVAC-HIV-1/protein boost vaccine strategy reduces SHIV RNA levels
Published in AIDS Weekly and Law, June 8th, 2006
"Transmission of human immunodeficiency virus type 1 (HIV-1) occurs primarily via the mucosal route, suggesting that HIV-1 vaccines may need to elicit mucosal immune responses. We investigated the immunogenicity and relative efficacy of systemic immunization with two human ALVAC-HIV-1 recombinant vaccines expressing Gag, Pol, and gp120 (vCP250) or Gag, Pol, and gp160 (vCP1420) in a prime-boost protocol with their homologous vaccine native Env...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly and Law
Source: AIDS Weekly and Law (2006-06-08)
More Articles from AIDS Weekly and Law
- Chembio Diagnostics, Inc.
Chembio supports CDC's recommendation for routine HIV testing - French National Institute of the Recherche Agronomique
Amino acid-glucose infusion improves leucine imbalance in PI-treated HIV/AIDS patients - U.S. Food & Drug Administration
Baseline protease genotype affects HIV response to atazanavir/ritonavir - Advanced BioScience Laboratories
Studies from the United States and United Kingdom describe new findings in HIV/AIDS research - AIDS Research Center, Palo Alto
Hepatitis C virus protease gene diversity exists in HIV coinfection - Attikon University General Hospital, Athens
Lopinavir-ritonavir associated with significant hypertriglyceridemia - More from this issue of AIDS Weekly and Law
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
